AZN240830C90000
- 0.06
- -0.15-71.43%
AstraZeneca Newsroom
5 Things You Need to Know About COVID, Flu and RSV Vaccines This Fall
Will vaccine production be transferred to the United States? Astrazeneca (AZN.US) denies: fake news.
AstraZeneca said the company is still engaged in constructive discussions with the United Kingdom government regarding the establishment of a vaccine facility in Speke, Liverpool.
AstraZeneca Threatens To Move Vaccine Production Amid Reduced State Support
AstraZeneca Warns on Relocating UK Vaccine Manufacturing to US
Market Chatter: AstraZeneca Reportedly Warned UK Government of Moving Vaccine Production to US; Company Refutes Media Claims
Update: AstraZeneca Denies Media Reports About Possible Vaccine Production Relocation From UK
Fitch Raises AstraZeneca's Rating on Robust Portfolio, Lower Leverage
Market Chatter: AstraZeneca Warns of Relocating UK Vaccine Production to US on Possible State Aid Cut
AstraZeneca was "stingy" by the new UK government: it will move its vaccine base to the United States!
①The previous united kingdom government promised to provide approximately 90 million British pounds to astrazeneca to support its development of research and production business in the United Kingdom; ②After the new government took office, it hopes to reduce the financial support to astrazeneca to 40 million British pounds, which has caused great dissatisfaction at astrazeneca.
AstraZeneca Warns of Moving UK Vaccine Production to US, FT Reports
Heard Writers Pick Their Favorite and Least-Favorite Stocks -- WSJ
FTC Says FDA Biosimilar Guidance Would Increase Competition, Lead to Lower Prices
Ozempic And Wegovy Linked to Increased Suicidal Thoughts In Observational Study, But Results Are Contested
Express News | WHO Official Hans Kluge Asserts Mpox Is Not The New COVID, Emphasizes Authorities Know How To Control Its Spread
European Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading
Johnson & Johnson Strikes $1.7B Deal To Acquire Heart-Tech Innovator V-Wave
Daiichi Sankyo/AstraZeneca (AZN.US) heavyweight ADC once again received breakthrough therapy recognition.
Enhertu is an ADC therapy developed jointly by Astrazeneca (AZN.US) and Daiichi Sankyo.
Johnson & Johnson Gets FDA Approval for Treatment, Makes Acquisition of Up to $1.7 Billion
AstraZeneca Is a Cancer Leader. Obesity Could Be a Bonus. -- Heard on the Street -- WSJ
Express News | China's National Medical Products Association Approves AstraZeneca's Fasenra (Benralizumab) For The Maintenance Treatment Of Patients 12 Years And Older With Severe Eosinophilic Asthma